BackBrowsing Artículos by Author "Gerovska, Daniela"
Now showing items 1-6 of 6
-
An Integrative Omics Approach Reveals Involvement of BRCA1 in Hepatic Metastatic Progression of Colorectal Cancer
; Larrinaga Embeita, Gorka
; ; Márquez Clavijo, Joana ; García Gallastegui, Patricia ; ; ; ; ; ; Badiola Echaburu, Iker ; (MDPI, 2020-08-22)
(1) Background & Aims: The roles of different cells in the tumor microenvironment (TME) are critical to the metastatic process. The phenotypic transformation of the liver cells is one of the most important stages of the ... -
GeromiRs Are Downregulated in the Tumor Microenvironment during Colon Cancer Colonization of the Liver in a Murine Metastasis Model
; García Gallastegui, Patricia; Crende Arruabarrena, Olatz ; Márquez Clavijo, Joana ; Larrinaga Embeita, Gorka ; ; ; Badiola Echaburu, Iker (MDPI, 2021-05-01)
Cancer is a phenomenon broadly related to ageing in various ways such as cell cycle deregulation, metabolic defects or telomerases dysfunction as principal processes. Although the tumor cell is the main actor in cancer ... -
HuR/ELAVL1 drives malignant peripheral nerve sheath tumor growth and metastasis
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; Izeta Permisán, Ander; ; ; ; ; ; ; Martínez Chantar, María Luz ; ; ; ; ; ; ; ; Carracedo Pérez, Arkaitz ; ; (The American Society for Clinical Investigation, 2020-07-01)
Cancer cells can develop a strong addiction to discrete molecular regulators, which control the aberrant gene expression programs that drive and maintain the cancer phenotype. Here, we report the identification of the ... -
PR-LncRNA Signature Regulates Glioma Cell Activity Through Expression of SOX Factors
; ; ; ; ; ; ; ; ; ; ; Ruiz Díaz, Irune; ; ; ; ; ; (Nature Publishing Group, 2018-08-24)
Long non-coding RNAs (LncRNAs) have emerged as a relevant class of genome regulators involved in a broad range of biological processes and with important roles in tumor initiation and malignant progression. We have previously ... -
Reiterative Infusions of MSCs Improve Pediatric Osteogenesis Imperfecta Eliciting a Pro-Osteogenic Paracrine Response: TERCELOI Clinical Trial
(John Wiley & Sons, 2021-01-13)Background Osteogenesis imperfecta (OI) is a rare genetic disease characterized by bone fragility, with a wide range in the severity of clinical manifestations. The majority of cases are due to mutations in the COL1A1 or ... -
Reiterative infusions of MSCs improve pediatric osteogenesis imperfecta eliciting a pro-osteogenic paracrine response: TERCELOI clinical trial
(Wiley, 2021-01-12)Background Osteogenesis imperfecta (OI) is a rare genetic disease characterized by bone fragility, with a wide range in the severity of clinical manifestations. The majority of cases are due to mutations in the COL1A1 or ...